Collectively, our study unveiled that CRSP8 functionalized as a novel pro-oncogenic protein by targeting IKKα in thyroid cancer, and conferred a therapeutic vulnerability for thyroid cancer treatment, especially ATC. The gene discussed is CHUK; the disease is thyroid gland carcinoma.